169 related articles for article (PubMed ID: 27604356)
1. Antitumoral Potential of Snake Venom Phospholipases A2 and Synthetic Peptides.
Sobrinho JC; Simões-Silva R; Holanda RJ; Alfonso J; Gomez AF; Zanchi FB; Moreira-Dill LS; Grabner AN; Zuliani JP; Calderon LA; Soares AM
Curr Pharm Biotechnol; 2016; 17(14):1201-1212. PubMed ID: 27604356
[TBL] [Abstract][Full Text] [Related]
2. Snake venom phospholipases A2: a new class of antitumor agents.
Rodrigues RS; Izidoro LF; de Oliveira RJ; Sampaio SV; Soares AM; Rodrigues VM
Protein Pept Lett; 2009; 16(8):894-8. PubMed ID: 19689415
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A2 by affinity binding studies and molecular bioinformatics.
Faure G; Gowda VT; Maroun RC
BMC Struct Biol; 2007 Dec; 7():82. PubMed ID: 18062812
[TBL] [Abstract][Full Text] [Related]
4. Emerging anticancer potential and mechanisms of snake venom toxins: A review.
Guo X; Fu Y; Peng J; Fu Y; Dong S; Ding RB; Qi X; Bao J
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131990. PubMed ID: 38704067
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of snake venom enzymatic toxins: phospholipase A2 and l-amino acid oxidase.
Hiu JJ; Yap MKK
Biochem Soc Trans; 2020 Apr; 48(2):719-731. PubMed ID: 32267491
[TBL] [Abstract][Full Text] [Related]
6. Insights into the antiviral activity of phospholipases A
Teixeira SC; Borges BC; Oliveira VQ; Carregosa LS; Bastos LA; Santos IA; Jardim ACG; Melo FF; Freitas LM; Rodrigues VM; Lopes DS
Int J Biol Macromol; 2020 Dec; 164():616-625. PubMed ID: 32698062
[TBL] [Abstract][Full Text] [Related]
7. Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential.
Marcussi S; Sant'Ana CD; Oliveira CZ; Rueda AQ; Menaldo DL; Beleboni RO; Stabeli RG; Giglio JR; Fontes MR; Soares AM
Curr Top Med Chem; 2007; 7(8):743-56. PubMed ID: 17456038
[TBL] [Abstract][Full Text] [Related]
8. Snake Venom PLA
Xiao H; Pan H; Liao K; Yang M; Huang C
Biomed Res Int; 2017; 2017():6592820. PubMed ID: 29318152
[TBL] [Abstract][Full Text] [Related]
9. Harnessing snake venom phospholipases A
Almeida JR; Palacios ALV; Patiño RSP; Mendes B; Teixeira CAS; Gomes P; da Silva SL
Drug Dev Res; 2019 Feb; 80(1):68-85. PubMed ID: 30255943
[TBL] [Abstract][Full Text] [Related]
10. Antitumoral potential of Tunisian snake venoms secreted phospholipases A2.
Zouari-Kessentini R; Srairi-Abid N; Bazaa A; El Ayeb M; Luis J; Marrakchi N
Biomed Res Int; 2013; 2013():391389. PubMed ID: 23509718
[TBL] [Abstract][Full Text] [Related]
11. Snake venom derived molecules in tumor angiogenesis and its application in cancer therapy; an overview.
Dhananjaya BL; Sivashankari PR
Curr Top Med Chem; 2015; 15(7):649-57. PubMed ID: 25714377
[TBL] [Abstract][Full Text] [Related]
12. A novel synthetic peptide inspired on Lys49 phospholipase A
Almeida JR; Mendes B; Lancellotti M; Marangoni S; Vale N; Passos Ó; Ramos MJ; Fernandes PA; Gomes P; Da Silva SL
Eur J Med Chem; 2018 Apr; 149():248-256. PubMed ID: 29501945
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of antitumor effect of recombinant sea snake basic phospholipase A2 to its enzymatic activity].
Liang YJ; Yang XP; Wei JW; Fu LW; Jiang XY; Chen SW; Yang WL
Ai Zheng; 2005 Dec; 24(12):1474-8. PubMed ID: 16351795
[TBL] [Abstract][Full Text] [Related]
14. Conservation analysis and decomposition of residue correlation networks in the phospholipase A2 superfamily (PLA2s): Insights into the structure-function relationships of snake venom toxins.
Oliveira A; Bleicher L; Schrago CG; Silva Junior FP
Toxicon; 2018 May; 146():50-60. PubMed ID: 29608922
[TBL] [Abstract][Full Text] [Related]
15. Antitumoral activity of snake venom proteins: new trends in cancer therapy.
Calderon LA; Sobrinho JC; Zaqueo KD; de Moura AA; Grabner AN; Mazzi MV; Marcussi S; Nomizo A; Fernandes CF; Zuliani JP; Carvalho BM; da Silva SL; Stábeli RG; Soares AM
Biomed Res Int; 2014; 2014():203639. PubMed ID: 24683541
[TBL] [Abstract][Full Text] [Related]
16. Calcium-independent membrane damage by venom phospholipases A2.
de Oliveira AH; Aragão EA; Sá JM; Chioato L; Bugs-Bortoleto R; Ruller R; Ferreira TL; Ward RJ
Protein Pept Lett; 2009; 16(8):877-86. PubMed ID: 19689413
[TBL] [Abstract][Full Text] [Related]
17. Crotoxin from Crotalus durissus terrificus venom: In vitro cytotoxic activity of a heterodimeric phospholipase A
Muller SP; Silva VAO; Silvestrini AVP; de Macedo LH; Caetano GF; Reis RM; Mazzi MV
Toxicon; 2018 Dec; 156():13-22. PubMed ID: 30395843
[TBL] [Abstract][Full Text] [Related]
18. Identification of the Molecular Determinants of the Antibacterial Activity of LmutTX, a Lys49 Phospholipase A
Diniz-Sousa R; Caldeira CAS; Kayano AM; Paloschi MV; Pimenta DC; Simões-Silva R; Ferreira AS; Zanchi FB; Matos NB; Grabner FP; Calderon LA; Zuliani JP; Soares AM
Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):413-423. PubMed ID: 29067765
[TBL] [Abstract][Full Text] [Related]
19. Myotoxic phospholipases A(2) isolated from Bothrops brazili snake venom and synthetic peptides derived from their C-terminal region: cytotoxic effect on microorganism and tumor cells.
Costa TR; Menaldo DL; Oliveira CZ; Santos-Filho NA; Teixeira SS; Nomizo A; Fuly AL; Monteiro MC; de Souza BM; Palma MS; Stábeli RG; Sampaio SV; Soares AM
Peptides; 2008 Oct; 29(10):1645-56. PubMed ID: 18602430
[TBL] [Abstract][Full Text] [Related]
20. Antitumor and Antiparasitic Activity of Antimicrobial Peptides Derived from Snake Venom: A Systematic Review Approach.
de Moura GA; de Oliveira JR; Rocha YM; de Oliveira Freitas J; Rodrigues JPV; Ferreira VPG; Nicolete R
Curr Med Chem; 2022; 29(32):5358-5368. PubMed ID: 35524668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
